Article
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
Cancer - 1 Mar 2008
Wheatley-Price Paul, Asomaning Kofi, Reid Amy, Zhai Rihong, Su Li, Zhou Wei, Zhu Andrew, Ryan David P, Christiani David C, Liu Geoffrey
Abstract excerpt
BACKGROUND: Pancreatic cancer risk has been linked to chronic pancreatitis and periodontitis, suggesting a role for inflammation in disease etiology. Myeloperoxidase (MPO) and superoxide dismutase (SOD2) are enzymes that regulate reactive oxygen species and contain recognized single nucleotide polymorphisms (SNPs) that confer altered enzyme activity. METHODS: One hundred twenty-two patients with pancreatic cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
